T2期胆囊癌肝切除策略:IVb段联合V段切除与楔形切除的倾向评分匹配研究
这项中国多中心回顾性倾向评分匹配研究比较了T2期胆囊癌行IVb+V段切除与楔形切除的安全性和有效性。匹配后两组总生存无统计学差异,但IVb+V段切除的无病生存更优,尤其见于意外胆囊癌、T2b期及淋巴结阴性患者,然而围术期并发症更多、住院时间更长。
要点
- IVb+V段切除较楔形切除改善T2期胆囊癌无病生存,总生存无差异。
- 意外胆囊癌、T2b期及淋巴结阴性者从IVb+V段切除中无病生存获益更明显。
- IVb+V段切除围术期并发症更多、住院时间更长,需权衡获益与风险。
核心结论
- T2期胆囊癌行IVb+V段切除较楔形切除改善无病生存,尤其意外胆囊癌或T2b期患者。
- IVb+V段切除围术期并发症发生率高且住院时间更长,术者需结合自身技术与患者情况决定肝切除策略。
研究设计与样本
- 中国多中心回顾性倾向评分匹配研究,共512例患者。
- 117例IVb+V段切除中112例与112例楔形切除进行匹配。
主要发现
- 匹配后IVb+V段切除与楔形切除总生存无统计学差异(HR 0.970 [0.639-1.474],P = .886)。
- IVb+V段切除无病生存优于楔形切除(HR 0.708 [0.506-0.991],P = .040)。
- 意外胆囊癌(HR 0.390 [0.180-0.846],P = .019)、T2b期(HR 0.515 [0.302-0.878],P = .016)及淋巴结阴性(HR 0.627 [0.406-0.991],P = .043)与IVb+V段切除后无病生存改善相关。
- IVb+V段切除围术期并发症更常见(28.5% vs 9.1%,P < .001),住院时间更长(17.3 vs 10.2天,P < .001)。
- IVb+V段切除组围术期并发症独立危险因素包括黄疸(OR 4.053 [1.361-12.23],P = .013)、腹腔镜切除(OR 2.387 [1.059-4.484],P = .028)及术者前10例IVb+V段切除(OR 2.697 [1.035-6.998],P = .041)。
临床怎么用
- 对意外胆囊癌或T2b期患者可优先考虑IVb+V段切除以改善无病生存。
- 术前黄疸、计划腹腔镜切除或术者处于学习曲线早期时,应警惕IVb+V段切除的围术期并发症风险。
局限性
- 回顾性多中心设计,可能存在选择偏倚。
- 倾向评分匹配后样本量有限,部分亚组分析效力不足。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Liver resection is recommended for T2 gallbladder cancer, but the optimal hepatectomy strategy remains controversial. We aimed to assess the safety and effectiveness of segment IVb and V resection versus wedge resection in patients with T2 gallbladder cancer. METHODS: This is a retrospective multicenter propensity score-matched study in China. Overall survival, disease-free survival, perioperative complications, and hospital length of stay were used to evaluate safety and effectiveness. RESULTS: There are a total of 512 patients. 112 of 117 patients undergoing segment IVb and V resection were matched to 112 patients undergoing wedge resection. After matching, segment IVb and V resection demonstrated no statistical difference in overall survival (hazard ratio, 0.970 [0.639-1.474]; P = .886), but significance in disease-free survival (hazard ratio, 0.708 [0.506-0.991]; P = .040). Patients with incidental gallbladder cancer (hazard ratio, 0.390 [0.180-0.846]; P = .019), stage T2b (hazard ratio, 0.515 [0.302-0.878]; P = .016), and negative lymph nodes status (hazard ratio, 0.627 [0.406-0.991]; P = .043) were associated with improved disease-free survival after segment IVb and V resection, but not in wedge resection. However, perioperative complications occurred more frequently after segment IVb and V resection (28.5% vs 9.1%, P < .001) along with the longer hospital length of stay (17.3 vs 10.2 days, P < .001). Notably, patients with jaundice (odds ratio, 4.053 [1.361-12.23]; P = .013), undergoing laparoscopic resection (odds ratio, 2.387 [1.059-4.484]; P = .028) or surgeon performing per the first 10 segment IVb and V resections (odds ratio, 2.697 [1.035-6.998]; P = .041), were the independent risk factors for perioperative complications in the segment IVb and V resection group. CONCLUSION: T2 gallbladder cancer patients undergoing segment IVb and V resection rather than wedge resection have an improved disease-free survival, especially for incidental gallbladder cancer or hepatic-sided (T2b) gallbladder cancer. However, high rates of perioperative complications and longer hospital length of stay after segment IVb and V resection indicated that surgeons must rely on their own surgical skills and the patient profile to decide the optimal hepatectomy strategy.
引用
- Chen M, Cao J, Xiang Y, et al. Hepatectomy strategy for T2 gallbladder cancer between segment IVb and V resection and wedge resection: A propensity score-matched study. Surgery. 2021. PMID: 33551070. doi:10.1016/j.surg.2020.12.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。